featured
Extended Genetic Profiling for Predicting Outcomes Following Lenalidomide Maintenance in Patients With Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Optimizing the value of lenalidomide maintenance by genetic profiling - an analysis of 556 Myeloma XI trial patients
Blood 2022 Dec 23;[EPub Ahead of Print], A Panopoulou, DA Cairns, AE Holroyd, I Nichols, N Cray, C Pawlyn, G Cook, MT Drayson, KD Boyd, FE Davies, MW Jenner, GJ Morgan, RG Owen, RS Houlston, GH Jackson, MF KaiserFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.